US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Completed

Camber Pharmaceuticals

Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Hetero Labs Limited Unit V NDC 31722-748-90 D-1116-2018
Class II · Moderate risk Completed

Camber Pharmaceuticals

Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Hetero Labs Limited Unit V NDC 31722-747-90 D-1115-2018
Class II · Moderate risk Completed

Camber Pharmaceuticals

Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Hetero Labs Limited Unit V NDC 31722-746-90 D-1114-2018
Class II · Moderate risk Completed

Camber Pharmaceuticals

Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Hetero Labs Limited Unit V NDC 31722-745-30 D-1113-2018
Class II · Moderate risk Terminated

Doxycycline Hyclate USP Tablets

Reason Failed Dissolution Specifications: manufacturer West-Ward Pharm Corp. recalled these repackaged lots due to failed dissolution results.

PD-Rx Pharmaceuticals, Inc. NDC 55289-866-02 D-1127-2018
Class II · Moderate risk Terminated

PIO&METFORMIN 15/1000 mg Tab 1

Reason Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.

Teva Pharmaceuticals USA D-0102-2019
Class II · Moderate risk Terminated

Metformin Hydrochloride Extended Release Tablets 1000 mg

Reason Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.

Teva Pharmaceuticals USA NDC 00591-2412-19 D-0101-2019
Class II · Moderate risk Terminated

Metformin Hydrochloride Extended Release Tablets 1000 mg

Reason Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.

Teva Pharmaceuticals USA NDC 00591-2720-60 D-0100-2019
Class II · Moderate risk Terminated

Metformin Hydrochloride Extended Release Tablets

Reason Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.

Teva Pharmaceuticals USA NDC 00591-2411-01 D-0099-2019
Class II · Moderate risk Terminated

Fortamet

Reason Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.

Teva Pharmaceuticals USA NDC 59630-575-60 D-0098-2019
Class II · Moderate risk Terminated

Paliperidone Extended Release Tablets 9 mg

Reason Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.

Teva Pharmaceuticals USA NDC 0591-3695-30 D-0097-2019
Class II · Moderate risk Terminated

Paliperidone Extended Release Tablets 3 mg

Reason Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.

Teva Pharmaceuticals USA NDC 0591-3693-30 D-0096-2019
Class II · Moderate risk Terminated

Family Dollar Saline Nasal Spray 4.25 oz. can

Reason CGMP Deviations: products manufactured under conditions that could impact its product quality.

Product Quest Manufacturing LLC D-0080-2019
Class II · Moderate risk Terminated

Finafta Baby

Reason CGMP Deviations: products manufactured under conditions that could impact its product quality.

Product Quest Manufacturing LLC D-0079-2019
Class II · Moderate risk Terminated

Rexall

Reason CGMP Deviations: products manufactured under conditions that could impact its product quality.

Product Quest Manufacturing LLC D-0078-2019
Class II · Moderate risk Terminated

Rexall

Reason CGMP Deviations: products manufactured under conditions that could impact its product quality.

Product Quest Manufacturing LLC D-0077-2019
Class II · Moderate risk Terminated

Rexall

Reason CGMP Deviations: products manufactured under conditions that could impact its product quality.

Product Quest Manufacturing LLC D-0076-2019
Class II · Moderate risk Terminated

Rhinall Nasal Decongestant Nasal Spray

Reason CGMP Deviations: products manufactured under conditions that could impact its product quality.

Product Quest Manufacturing LLC D-0075-2019
Class II · Moderate risk Terminated

CVS Health

Reason Subpotent Drug: low out of specification assay results for the bacitracin zinc ingredient.

Product Quest Manufacturing LLC D-0073-2019
Class II · Moderate risk Terminated

Mushatt's No. 9

Reason Microbial Contamination of Non-Sterile Products and Subpotent Drug: failure for microbiological growth exceeding specification and low out of specification assay results for salicylic acid.

Product Quest Manufacturing LLC D-0072-2019
Class II · Moderate risk Terminated

CeraVe Healing Lip Balm/SPF 30

Reason Microbial Contamination of Non-Sterile Products: Failed microbiological testing for Staphalococcus aureus.

Product Quest Manufacturing LLC D-0071-2019
Class II · Moderate risk Terminated

Premier Value

Reason Superpotent Drug: high out of specification assay results for the menthol ingredient.

Product Quest Manufacturing LLC D-0068-2019
Class II · Moderate risk Terminated

Rite Aid Pharmacy

Reason Subpotent Drug: low out of specification assay results for the bacitracin zinc ingredient.

Product Quest Manufacturing LLC D-0067-2019
Class II · Moderate risk Terminated

Freeze It

Reason Superpotent Drug: high out of specification assay results for the camphor ingredient.

Product Quest Manufacturing LLC D-0066-2019
Class II · Moderate risk Terminated

dr. brandt

Reason Failed Stability Specifications: separation of product and failure for actives.

Product Quest Manufacturing LLC D-0065-2019